|
| 產(chǎn)地 | 進口、國產(chǎn) |
| 品牌 | 上海莼試 |
| 保存條件 | Store at -20 °C |
| 貨號 | CS11288 |
| 應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 |
| CAS編號 | |
| 抗體名 | Anti-phospho-c-Abl(Ser569) |
| 克隆性 | |
| 靶點 | 詳見說明書 |
| 適應(yīng)物種 | 詳見說明書 |
| 形態(tài) | 詳見說明書 |
| 宿主 | 詳見說明書 |
| 亞型 | IgG |
| 標(biāo)識物 | 詳見說明書 |
| 濃度 | 1mg/1ml% |
| 免疫原 | KLH conjugated synthesised phosphopeptide derived from human c-Abl isoform a around the phosphorylation site of Ser569 |
磷酸化非受體酪氨酸激酶c-Abl抗體說明書 英文名稱 Anti-phospho-c-Abl(Ser569)
中文名稱 磷酸化非受體酪氨酸激酶c-Abl抗體說明書
別 名 c Abl(phospho S569); p-c Abl(phospho S569); p-c Abl(phospho Ser569); Abelson Murine Leukemia Viral Oncogene Homolog 1; Abelson murine leukemia viral v abl oncogene homolog 1; Abl 1; ABL; Abl protein; Abl1; Bcr/c abl oncogene protein; JTK 7; JTK7; p150 ; Proto oncogene tyrosine protein kinase ABL1; Transformation gene oncogene ABL; v abl Abelson murine leukemia viral oncogene homolog 1; v abl; ABL1_HUMAN.
產(chǎn)品屬性：
濃 度 1mg/1ml
規(guī) 格 0.1ml/100μg
抗體來源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Pig, Cow, Horse, Sheep
產(chǎn)品類型 一抗 磷酸化抗體
研究領(lǐng)域 細胞生物 信號轉(zhuǎn)導(dǎo) 細胞凋亡 轉(zhuǎn)錄調(diào)節(jié)因子 激酶和磷酸酶 線粒體
蛋白分子量 predicted molecular weight: 123kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthesised phosphopeptide derived from human c-Abl isoform a around the phosphorylation site of Ser569
亞 型 IgG
純化方法 affinity purified by Protein A
儲 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
磷酸化非受體酪氨酸激酶c-Abl抗體說明書 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 The ABL1 protooncogene encodes a cytoplasmic and nuclear protein tyrosine kinase that has been implicated in processes of cell differentiation, cell division, cell adhesion, and stress response. Activity of c-Abl protein is negatively regulated by its SH3 domain, and deletion of the SH3 domain turns ABL1 into an oncogene. The t(9;22) translocation results in the head-to-tail fusion of the BCR (MIM:151410) and ABL1 genes present in many cases of chronic myelogeneous leukemia. The DNA-binding activity of the ubiquitously expressed ABL1 tyrosine kinase is regulated by CDC2-mediated phosphorylation, suggesting a cell cycle function for ABL1. The ABL1 gene is expressed as either a 6- or 7-kb mRNA transcript, with alternatively spliced first exons spliced to the common exons 2-11. [provided by RefSeq].
Function : Non-receptor tyrosine-protein kinase that plays a role in many key processes linked to cell growth and survival such as cytoskeleton remodeling in response to extracellular stimuli, cell motility and adhesion, receptor endocytosis, autophagy, DNA damage response and apoptosis. Coordinates actin remodeling through tyrosine phosphorylation of proteins controlling cytoskeleton dynamics like WASF3 (involved in branch formation); ANXA1 (involved in membrane anchoring); DBN1, DBNL, CTTN, RAPH1 and ENAH (involved in signaling); or MAPT and PXN (microtubule-binding proteins). Phosphorylation of WASF3 is critical for the stimulation of lamellipodia formation and cell migration. Involved in the regulation of cell adhesion and motility through phosphorylation of key regulators of these processes such as BCAR1, CRK, CRKL, DOK1, EFS or NEDD9. Phosphorylates multiple receptor tyrosine kinases and more particularly promotes endocytosis of EGFR, facilitates the formation of neuromuscular synapses through MUSK, inhibits PDGFRB-mediated chemotaxis and modulates the endocytosis of activated B-cell receptor complexes. Other substrates which are involved in endocytosis regulation are the caveolin (CAV1) and RIN1. Moreover, ABL1 regulates the CBL family of ubiquitin ligases that drive receptor down-regulation and actin remodeling. Phosphorylation of CBL leads to increased EGFR stability. Involved in late-stage autophagy by regulating positively the trafficking and function of lysosomal components. ABL1 targets to mitochondria in response to oxidative stress and thereby mediates mitochondrial dysfunction and cell death. ABL1 is also translocated in the nucleus where it has DNA-binding activity and is involved in DNA-damage response and apoptosis. Many substrates are known mediators of DNA repair: DDB1, DDB2, ERCC3, ERCC6, RAD9A, RAD51, RAD52 or WRN. Activates the proapoptotic pathway when the DNA damage is too severe to be repaired. Phosphorylates TP73, a primary regulator for this type of damage-induced apoptosis. Phosphorylates PSMA7 that leads to an inhibition of proteasomal activity and cell cycle transition blocks. ABL1 acts also as a regulator of multiple pathological signaling cascades during infection. Several known tyrosine-phosphorylated microbial proteins have been identified as ABL1 substrates. This is the case of A36R of Vaccinia virus, Tir (translocated intimin receptor) of pathogenic E.coli and possibly Citrobacter, CagA (cytotoxin-associated gene A) of H.pylori, or AnkA (ankyrin repeat-containing protein A) of A.phagocytophilum. Pathogens can highjack ABL1 kinase signaling to reorganize the host actin cytoskeleton for multiple purposes, like facilitating intracellular movement and host cell
Subunit : Interacts with SORBS1 following insulin stimulation. Found in a trimolecular complex containing CDK5 and CABLES1. Interacts with CABLES1 and PSTPIP1. Interacts with ZDHHC16, ITGB1 and HCK (By similarity). Interacts with INPPL1/SHIP2. Interacts with the 14-3-3 proteins, YWHAB, YWHAE, YWHAG, YWHAH, SFN AND YWHAZ; the interaction with 14-3-3 proteins requires phosphorylation on Thr-735 and, sequesters ABL1 into the cytoplasm. Interacts with ABI1, ABI2, BCR, CRK, FGR, FYN, HCK, LYN, PSMA7 RAD9A, RAD51, RAD52, TP73 and WASF3. A complex made of ABL1, CTTN and MYLK regulates cortical actin-based cytoskeletal rearrangement critical to sphingosine 1-phosphate (S1P)-mediated endothelial cell (EC) barrier enhancement.
Subcellular Location : Cytoplasm, cytoskeleton. Nucleus. Mitochondrion. Note=Shuttles between the nucleus and cytoplasm depending on environmental signals. Sequestered into the cytoplasm through interaction with 14-3-3 proteins. Localizes to mitochondria in response to oxidative stress. Isoform IB: Nucleus membrane; Lipid-anchor. Note=The myristoylated c-ABL protein is reported to be nuclear.
Tissue Specificity : Widely expressed.
Post-translational modifications : Acetylated at Lys-711 by EP300 which promotes the cytoplasmic translocation. Phosphorylation at Tyr-70 by members of the SRC family of kinases disrupts SH3 domain-based autoinhibitory interactions and intermolecular associations, such as that with ABI1, and also enhances kinase activity. Phosphorylation at Tyr-226 and Tyr-393 correlate with increased activity. DNA damage-induced activation of ABL1 requires the function of ATM and Ser-446 phosphorylation. Phosphorylation at Ser-569 has been attributed to a CDC2-associated kinase and is coupled to cell division. Phosphorylation at Ser-618 and Ser-619 by PAK2 increases binding to CRK and reduces binding to ABI1. Phosphorylation on Thr-735 is required for binding 14-3-3 proteins for cytoplasmic translocation. Phosphorylated by PRKDC
DISEASE : Note=A chromosomal aberration involving ABL1 is a cause of chronic myeloid leukemia. Translocation t(9;22)(q34;q11) with BCR. The translocation produces a BCR-ABL found also in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).
Similarity : Belongs to the protein kinase superfamily. Tyr protein kinase family. ABL subfamily.
Contains 1 protein kinase domain.
Contains 1 SH2 domain.
Contains 1 SH3 domain.
Database links : UniProtKB/Swiss-Prot: P00519.4
實驗流程：
全、新、優(yōu)、品、好四大特點：
磷酸化非受體酪氨酸激酶c-Abl抗體說明書 全：公司提供上萬種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標(biāo)準(zhǔn)品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細胞等，基本上各種科研所需產(chǎn)品在我司都能找到。
新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。
優(yōu)：產(chǎn)品質(zhì)量好，投訴比較少。
好：我公司具有優(yōu)質(zhì)的技術(shù)團隊，產(chǎn)品一旦售出，實驗過程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時沒有任何的后顧之憂。
正在熱銷的相關(guān)產(chǎn)品：
PHD3 (Egln3; HIF-prolyl hydroxylase 3) 脯氨酸羥化酶(多肽)Multi-class antibodies規(guī)格： 0.5mg
Anti-B7-DC/CD273 程序性死亡配體2抗體Multi-class antibodies規(guī)格： 0.1ml
Rhesus antibody Rh phospho-ADRB2(Ser346) 磷酸化能受體β2抗體 規(guī)格 0.1ml
Mast Cell Tryptase 濃縮液 0.1ml 進口分裝
USE1 英文名稱： 囊泡轉(zhuǎn)運蛋白Use1抗體 0.2ml
CHODL 英文名稱： 軟骨凝集蛋白CHODL抗體 0.1ml
Anti-B7-DC/CD273 程序性死亡配體2抗體Multi-class antibodies規(guī)格： 0.1ml
Anti-phospho-c-Raf (Ser338) /FITC 熒光素標(biāo)記磷酸化原癌基因c-Raf抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Rabbit Anti-Bovine IgG 兔抗IgG (親和層析純化)Multi-class antibodies規(guī)格： 1mg
GDNF家族受體α-1抗體 Anti-GFRα-1/GDNF 0.1ml
Rabbit Anti-chicken IgG/HRP 辣根過氧化物酶標(biāo)記的兔抗雞IgG 0.1ml
FAR2 英文名稱： 脂肪酰輔酶A還原酶2抗體 0.2ml
Rhesus antibody Rh Phospho-Smad1(Ser206) 磷酸化細胞信號轉(zhuǎn)導(dǎo)分子Smad-1抗體 規(guī)格 0.1ml
Rabbit Anti-Bovine IgG 兔抗IgG (親和層析純化)Multi-class antibodies規(guī)格： 1mg
SKP1 英文名稱： S期激酶相關(guān)蛋白1抗體 0.2ml
alpha Elastin 英文名稱： α彈性蛋白抗體 0.1ml
轉(zhuǎn)移生長因子–β受體1抗體 Anti-TGF-βR1/ALK 0.1ml
Anti-TM/FITC 熒光素標(biāo)記調(diào)節(jié)蛋白抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh Phospho-LAT (Tyr191) 磷酸化T細胞活化連接蛋白抗體 規(guī)格 0.1ml
OPN 骨橋蛋白(多肽抗原)Multi-class antibodies規(guī)格： 0.5mg
HCT116, 人結(jié)細胞
LX-2 人肝星形細胞
FCGR3 Others Cynomolgus 食蟹猴 CD16 / FCGR3 人細胞裂解液 (陽性對照)
中國倉鼠卵巢細胞(亞系克隆);DUKXB11 carrying pDEF202-hTPO-P1
淋巴成纖維細胞Many types of cells包裝：5 × 105次方(1ml)
TNFa轉(zhuǎn)染耐VP16絨癌細胞;JEG-3-VP16-TNFa 大鼠肝實質(zhì)細胞完全培養(yǎng)基 100mL
6-10B, 人細胞系
MS4A1 Others Human 人 CD20 / MS4A1 (aa 213-297) 人細胞裂解液 (陽性對照)
大鼠表皮黑色素細胞完全培養(yǎng)基 100mL
LLC-MK2恒河猴腎細胞 Ganges RIver LLC-MK2 monkey kidney cells RPMI-1640(GIBCO)+10%FBS
IFNA4 Protein Human 重組人 IFNα4 / IFNa4 / Ierferon alpha-4 蛋白 (His 標(biāo)簽)
MDA-MB-175VII(人導(dǎo)管癌細胞) 5×106cells/瓶×2 BRL 3A(大鼠肝細胞)
磷酸化非受體酪氨酸激酶c-Abl抗體說明書 HCT116, 人結(jié)細胞
LX-2 人肝星形細胞
FCGR3 Others Cynomolgus 食蟹猴 CD16 / FCGR3 人細胞裂解液 (陽性對照)
中國倉鼠卵巢細胞(亞系克隆);DUKXB11 carrying pDEF202-hTPO-P1
淋巴成纖維細胞Many types of cells包裝：5 × 105次方(1ml)
TNFa轉(zhuǎn)染耐VP16絨癌細胞;JEG-3-VP16-TNFa 大鼠肝實質(zhì)細胞完全培養(yǎng)基 100mL
技術(shù)外包服務(wù):
★磷酸化非受體酪氨酸激酶c-Abl抗體說明書 分子生物學(xué)：質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué)：基因合成、引物合成、基因測序、載體構(gòu)建等
★蛋白工程：原核、哺乳動物蛋白表達系統(tǒng)等
★病毒包裝：腺病毒、慢病毒等
★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
★細胞工程：細胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細胞培養(yǎng)、細胞膜制備、穩(wěn)定細胞株構(gòu)建、細胞RNAi技術(shù)等等。
|
|
|
|
|
